Inspire Medical Systems I... (INSP)
192.56
8.21 (4.45%)
At close: Jan 28, 2025, 1:44 PM
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems Inc.
| Country | United States |
| IPO Date | May 3, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 1,011 |
| CEO | Timothy P. Herbert |
Contact Details
Address: 5500 Wayzata Boulevard Golden Valley, Minnesota United States | |
| Website | https://www.inspiresleep.com |
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| Employer ID | 26-1377674 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Timothy P. Herbert | Founder, Chairman, Chief Executive Officer & President |
| John C. Rondoni | Chief Technology Officer |
| Melissa J. Mann | Chief People Officer |
| Richard J. Buchholz | Chief Financial Officer |
| Andreas Henke | Executive Vice President & MD of Europe |
| Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
| Carlton W. Weatherby | Chief Strategy and Growth Officer |
| Ezgi Yagci | Vice President of Investor Relations |
| Ivan Lubogo | SVice President of Strategic Sales |
| Randall A. Ban | EVice President of Patient Access &Therapy Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 17, 2025 | 4 | Filing |
| Jan 17, 2025 | 4 | Filing |
| Jan 17, 2025 | 4 | Filing |
| Jan 17, 2025 | 4 | Filing |
| Jan 13, 2025 | 8-K | Current Report |
| Jan 10, 2025 | 4 | Filing |
| Dec 23, 2024 | 4 | Filing |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 05, 2024 | 4 | Filing |